[{"address1": "30 Technology Drive", "city": "Warren", "state": "NJ", "zip": "07059", "country": "United States", "phone": "908 941 1900", "website": "https://www.aquestive.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.", "fullTimeEmployees": 142, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Barber", "age": 48, "title": "CEO, President & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 1063506, "exercisedValue": 0, "unexercisedValue": 81300}, {"maxAge": 1, "name": "Mr. A. Ernest Toth Jr.", "age": 65, "title": "Chief Financial Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 667187, "exercisedValue": 0, "unexercisedValue": 11400}, {"maxAge": 1, "name": "Ms. Lori J. Braender BSBA, Esq., J.D.", "age": 68, "title": "Chief Legal Officer, Chief Compliance Officer &Secretary", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 713215, "exercisedValue": 0, "unexercisedValue": 40200}, {"maxAge": 1, "name": "Ms. Cassie  Jung", "age": 45, "title": "Chief Operating Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Wargacki Ph.D.", "age": 46, "title": "Chief Science Officer", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sherry  Korczynski", "title": "Senior Vice President of Sales & Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter E. Boyd", "age": 58, "title": "Senior Vice President of Information Technology & Human Resources", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gary H. Slatko M.D., MBA", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Carl N. Kraus M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Charles Arnold", "title": "VP of Finance, Controller & Assistant Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 5, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.85, "open": 2.82, "dayLow": 2.79, "dayHigh": 2.895, "regularMarketPreviousClose": 2.85, "regularMarketOpen": 2.82, "regularMarketDayLow": 2.79, "regularMarketDayHigh": 2.895, "payoutRatio": 0.0, "beta": 2.591, "forwardPE": -4.783333, "volume": 669162, "regularMarketVolume": 669162, "averageVolume": 1581584, "averageVolume10days": 1037000, "averageDailyVolume10Day": 1037000, "bid": 2.08, "ask": 3.58, "bidSize": 1, "askSize": 2, "marketCap": 283760896, "fiftyTwoWeekLow": 2.2, "fiftyTwoWeekHigh": 5.8, "priceToSalesTrailing12Months": 4.9297423, "fiftyDayAverage": 2.8337, "twoHundredDayAverage": 3.79535, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 250218832, "profitMargins": -0.76679003, "floatShares": 94253087, "sharesOutstanding": 98871400, "sharesShort": 10021362, "sharesShortPriorMonth": 9978681, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.1014, "heldPercentInsiders": 0.05045, "heldPercentInstitutions": 0.48471, "shortRatio": 7.49, "shortPercentOfFloat": 0.1195, "impliedSharesOutstanding": 98871400, "bookValue": -0.658, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -44137000, "trailingEps": -0.51, "forwardEps": -0.6, "enterpriseToRevenue": 4.347, "enterpriseToEbitda": -8.332, "52WeekChange": -0.23159301, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 2.87, "targetHighPrice": 15.0, "targetLowPrice": 4.75, "targetMeanPrice": 9.86111, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 9, "totalCash": 71546000, "totalCashPerShare": 0.724, "ebitda": -30030000, "totalDebt": 38004000, "quickRatio": 4.182, "currentRatio": 4.676, "totalRevenue": 57561000, "revenuePerShare": 0.664, "returnOnAssets": -0.24215001, "grossProfits": 39689000, "freeCashflow": -10494500, "operatingCashflow": -35759000, "revenueGrowth": -0.101, "grossMargins": 0.68951, "ebitdaMargins": -0.52171004, "operatingMargins": -1.1442701, "financialCurrency": "USD", "symbol": "AQST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Aquestive Therapeutics, Inc.", "longName": "Aquestive Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532525400000, "postMarketChangePercent": 2.08363, "postMarketPrice": 2.9298, "postMarketChange": 0.0598001, "regularMarketChange": 0.01999998, "regularMarketDayRange": "2.79 - 2.895", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1581584, "fiftyTwoWeekLowChange": 0.66999984, "fiftyTwoWeekLowChangePercent": 0.30454537, "fiftyTwoWeekRange": "2.2 - 5.8", "fiftyTwoWeekHighChange": -2.9300003, "fiftyTwoWeekHighChangePercent": -0.50517243, "fiftyTwoWeekChangePercent": -23.159302, "earningsTimestamp": 1741208460, "earningsTimestampStart": 1746442740, "earningsTimestampEnd": 1746792000, "earningsCallTimestampStart": 1741266000, "earningsCallTimestampEnd": 1741266000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.51, "epsForward": -0.6, "epsCurrentYear": -0.64, "priceEpsCurrentYear": -4.484375, "fiftyDayAverageChange": 0.036299944, "fiftyDayAverageChangePercent": 0.012810088, "twoHundredDayAverageChange": -0.9253502, "twoHundredDayAverageChangePercent": -0.24381155, "priceToBook": -4.361702, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1745624320, "regularMarketTime": 1745611202, "exchange": "NGM", "messageBoardId": "finmb_8142504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.70175374, "regularMarketPrice": 2.87, "marketState": "CLOSED", "displayName": "Aquestive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]